Block Rao

B Rao – Business, Finance & Digital Asset Analyst B Rao is a seasoned financial analyst and digital asset strategist, specializing in crypto market analysis, macroeconomic trends, and blockchain innovations. As a lead contributor at MoneyOye.com, he delivers in-depth research and expert insights into equities, decentralized finance (DeFi), and emerging fintech trends. With a strong focus on market analysis, regulatory developments, and institutional adoption of digital assets, Praveen simplifies complex financial concepts for investors and businesses alike. His research-backed approach and ability to decode industry trends have made him a trusted voice in the finance and crypto industry.

Grok-3 outperformed OpenAI’s GPT-4 and Google’s Gemini in early benchmarking

Elon Musk’s xAI Unveils Grok-3: A New AI Powerhouse Challenging GPT-4 and Gemini Elon Musk’s artificial intelligence company, xAI, has just unveiled its latest and most powerful AI model, Grok-3. This AI system is being described as a significant leap forward, with more than 10 times the computing power of its predecessor, Grok-2. According to xAI, early testing…

Read More

What is DOGE Dividend? Will All Americans Get a $5,000 Refund Check from Elon Musk?

A new financial proposal is making waves across the United States: the DOGE Dividend. According to this proposal, American taxpayers could receive a refund check of $5,000, thanks to savings from the Department of Government Efficiency (DOGE), led by Elon Musk. But how real is this idea? And could this actually happen? Let’s dive in. 📌 The DOGE Dividend Explained The proposal, floated by James…

Read More

Trump & Musk Drop a DOGE Bombshell—Is This the Ultimate Crypto Pump of 2025?

Introduction The word “DOGE” is trending again, but this time it’s not just about the popular cryptocurrency Dogecoin. Instead, it’s about a new initiative called the Department of Government Efficiency (DOGE), introduced by former President Donald Trump, with Elon Musk playing a key advisory role. This has sparked widespread speculation and confusion, especially given Musk’s long history of influencing…

Read More

Zealand Pharma Announces Financial Results for the Full Year 2024

Company announcement – No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity pipeline, while building the foundation for accelerated growth in the years to come Positive results with long-acting amylin analog petrelintide in 16-week Phase 1b trial and advancement into…

Read More